NCT03806972 Short and Long Term Prognosis of Patients Admitted to the ED With Acute Heart Failure
| NCT ID | NCT03806972 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Monastir |
| Condition | Acute Heart Failure |
| Study Type | OBSERVATIONAL |
| Enrollment | 3,000 participants |
| Start Date | 2009-06-01 |
| Primary Completion | 2030-12-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 3,000 participants in total. It began in 2009-06-01 with a primary completion date of 2030-12-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Heart failure (HF) is the leading cause of hospitalization ,rehospitalization and mortality for adults over 65 years of age. This study aimed to assess mortality, and hospitalization rates at 30 days and one year after dicharge of patients with heart failure (HF) with reduced ejection fraction (HFrEF) compared to HF with preserved ejection fraction (HFpEF).
Eligibility Criteria
Inclusion Criteria: * patients admitted to the ED of Monastir with a principal discharge diagnosis code for HF. Exclusion Criteria: * Pregnant or breast feeding women. Alteration of consciousness GCS \< 15 Critically ill patients needing immediate mechanical hemodynamic of ventilatory support. Inability to follow instructions or comply with follow-up procedures.
Contact & Investigator
Nouira Semir, Professor
PRINCIPAL INVESTIGATOR
university Hospital of Monastir
Frequently Asked Questions
Who can join the NCT03806972 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 80 Years, studying Acute Heart Failure. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT03806972 currently recruiting?
Yes, NCT03806972 is actively recruiting participants. Contact the research team at semir.nouira@rns.tn for enrollment information.
Where is the NCT03806972 trial being conducted?
This trial is being conducted at Monastir, Tunisia.
Who is sponsoring the NCT03806972 clinical trial?
NCT03806972 is sponsored by University of Monastir. The principal investigator is Nouira Semir, Professor at university Hospital of Monastir. The trial plans to enroll 3,000 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.